Cancer Chemotherapy and Pharmacology

SJR Rank #6,299H-index: 132SJR: 0.851Best quartile: Q2Open AccessAPC: US$4,390
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • OncologyQ2
  • PharmacologyQ2
  • Pharmacology (medical)Q2
  • ToxicologyQ2
  • Cancer ResearchQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Cancer Treatment and PharmacologyCancer therapeutics and mechanismsColorectal Cancer Treatments and StudiesLung Cancer Research StudiesLung Cancer Treatments and MutationsChemotherapy-induced organ toxicity mitigationDrug Transport and Resistance MechanismsChemotherapy-induced cardiotoxicity and mitigationAcute Lymphoblastic Leukemia researchHER2/EGFR in Cancer Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

2022202503570105140

Detailed Information

ISSN

1432-0843, 0344-5704

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.44

References per Document

40.74

Coverage

1978-2026

Scope

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

Metrics from SCImago Journal Rank 2025. View on SCImago